Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04XWX
|
|||
| Former ID |
DIB003581
|
|||
| Drug Name |
PS-178990
|
|||
| Synonyms |
SARMs (muscle wasting disease), BMS; SARMs (muscle wasting disease), Ligand; SARMs (muscle wasting disease), Pharmacopeia; Selective androgen receptor modulators (muscle wasting disease), BMS; Selective androgen receptor modulators (muscle wasting disease), Ligand; Selective androgen receptor modulators (muscle wasting disease), Pharmacopeia
Click to Show/Hide
|
|||
| Indication | Muscle atrophy [ICD-11: FB32.Y] | Phase 1 | [1] | |
| Company |
Bristol-Myers Squibb Co
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027228) | |||
| REF 2 | Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008; 6: e010. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.